$CGNX

Cognex buys Israel-based RealSense for over $600m

Cognex Corp. (CGNX) acquired RealSense, an Israeli depth cameras and computer-vision systems company, for over $600 million. The deal includes $500 million in cash, $56.5 million in a retention program, and $50 million in restricted stock units. RealSense, spun off from Intel in 2024, is projected to reach $80-90 million in revenue by 2026 and become profitable, driving Cognex's acquisition decision.

Original reporting
Published Sep 22, 2026, 12:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 22, 2026, 12:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cognex buys Israel-based RealSense for over $600m — source image
Decision brief

The 30-second read

$CGNXBullishHigh
01

Why it matters

The acquisition positions Cognex in high‑growth robotics markets and diversifies its product line.

02

Market read

First‑report M&A deal worth >$600M; likely to move CGNX stock and influence the broader industrial automation sector.

03

What to watch

Potential regulatory review in the U.S. and EU could delay closing.

Relevance 9/10Novelty 9/10Timing: announcement today

Background

Cognex (CGNX) is a leading provider of machine‑vision and barcode solutions; RealSense develops depth‑camera technology.

Company-level read

Ticker impact

$CGNXBullishHigh confidence
Context

Cognex announced acquisition of RealSense for over $600 million, cash and RSU consideration.

Expected impact

Potential short‑term upside as investors price in the strategic acquisition.

Evidence & confidence

Large M&A transaction disclosed for the first time; market typically reacts positively to strategic add‑ons.

Market effects

Strengthens the machine‑vision sector and may spur consolidation activity.

Highlights Israel’s growing role in industrial robotics and AI hardware.

Adds to the competitive landscape against rivals like Keyence and Omron worldwide.

Counterpoint

Deal could be over‑priced; integration risk may weigh on Cognex earnings.

Key entities

  • Cognex Corp.

    US‑listed machine‑vision firm acquiring RealSense.

  • RealSense

    Israel‑based depth‑camera and computer‑vision startup.

Related articles

$CGNXMed

CGNX Maintained by Barclays -- Price Target Raised to $85.00

Barclays maintained an Overweight rating on Cognex (CGNX) and raised its price target to $85.00 from $80.00. The company's GF Value™ suggests it is 15.6% overvalued, while its GF Score™ is 86/100. Cognex is a leading manufacturer of machine vision systems, with a market cap of $10.38 billion. Insider activity shows mixed sentiment, with some gurus adding positions while others trimmed.

$CGNXMed

Why Cognex (CGNX) Stock Is Falling Today

Cognex (CGNX) shares fell 7.5% due to rising Treasury yields, oil prices, and a Truist price target cut to $74. The company's stock is volatile, up 67.5% YTD but down 14.6% from its 52-week high. Truist expects constructive company commentary despite near-term challenges.

$CGNXHighAI 9/10

Shifting to physical AI, Cognex to acquire RealSense in $500 million deal

Cognex Corporation is acquiring RealSense, an Israeli AI vision technology developer, for $500 million in cash and a $50 million stock option. The deal, expected to close in Q4 2026, will expand Cognex into robotic perception and Physical AI. RealSense, with 180 employees, is a key supplier for autonomous robots and expects $80-90 million in 2026 revenue, up over 50% year-over-year.